RxDoctor Payments Data

Mary Carleton Johnston, MD

Gynecology · Mobile, ALNPI 1376034298

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 25.1% of the total.

$895in general payments, 2019–2025

Across 52 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$225
  • Sumitomo Pharma America, Inc.$175
  • Daiichi Sankyo Inc.$81
  • Intuitive Surgical$79
  • Coopersurgical, Inc.$76
  • Sage Therapeutics, LLC$70
  • plus $189 from 8 others

What the payments were for

  • Food & beverage$87698%
  • Education$192%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$895 in reported general payments places this provider in the 70th percentile of 51 gynecology providers in Alabama.

See all gynecology providers in Alabama

Medicare billing

Part B allowed, 2024
$10,476
Medicare patients
35
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron24$14,148
Estradiol105$5,986
Clobetasol Propionate59$1,441
ProgesteroneProgesterone, Micronized16$830
Fluconazole55$463
Medroxyprogesterone Acetate26$318
Metronidazole26$305
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet16$294
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$227
Oxybutynin Chloride ErOxybutynin Chloride13$101
Naproxen11$80
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$50

Paid to pharmacies, not to this prescriber.

Other gynecology in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →